RecruitingPhase 2NCT04862221
TReatment for ImmUne Mediated PathopHysiology
Studying Acute liver failure
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Principal Investigator
- Estella M Alonso, MDAnn & Robert H Lurie Children's Hospital of Chicago
- Intervention
- High-dose methylprednisolone(drug)
- Enrollment
- 163 enrolled
- Eligibility
- 1-18 years · All sexes
- Timeline
- 2022 – 2027
Study locations (24)
- Children's Hospital Los Angeles, Los Angeles, California, United States
- Lucile Packard Children's Hospital, Palo Alto, California, United States
- Rady Children's Hospital, San Diego, California, United States
- University of California San Francisco Benioff Children's Hospital, San Francisco, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- Yale New Haven Children's Hospital, New Haven, Connecticut, United States
- Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta, Georgia, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- Riley Hospital for Children, Indianapolis, Indiana, United States
- Children's Hospital Boston, Boston, Massachusetts, United States
- The Children's Mercy Hospital, Kansas City, Missouri, United States
- St. Louis Children's Hospital, St Louis, Missouri, United States
- The Mount Sinai Medical Center, New York, New York, United States
- NYP Morgan Stanley Children's Hospital, New York, New York, United States
- Duke University Medical Center - Duke Children's, Durham, North Carolina, United States
- +9 more locations on ClinicalTrials.gov
Collaborators
Ann & Robert H Lurie Children's Hospital of Chicago
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04862221 on ClinicalTrials.govOther trials for Acute liver failure
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT07409259PT-MSCs Exosome Injection in the Treatment of Chronic-to-acute Liver FailureThird Affiliated Hospital, Sun Yat-Sen University
- ENROLLING BY INVITATIONNANCT06987604Continuous Renal Replacement Therapy Intensity in HyperammonemiaHospital de Clinicas de Porto Alegre
- RECRUITINGNANCT06831643Standard Volume vs. High Volume Plasma Exchange in Pediatric Acute Liver FailureInstitute of Liver and Biliary Sciences, India
- ACTIVE NOT RECRUITINGNANCT06872372Role of N-Acetylcysteine in Non-Acetaminophen-Induced Acute Liver FailureLahore General Hospital
- RECRUITINGNCT06908746Efficacy and Safety of Citrate Anticoagulation in CRRT for Patients With Liver Failure/DysfuncTION, the CAUTION Trial! A Retrospective Study on Etiology of Liver Failure and Their ComplicationsUniversity Hospital, Antwerp
- ENROLLING BY INVITATIONNCT06893042Clinical Study of Pediatric Acute Liver FailureFansen Zeng
- RECRUITINGNANCT07329036ALSS - DPMAS and Therapeutic Plasma Exchange (TPE), Its Effect on Primary Coagulation, Inflammation and the Function of Vital Organs in ALF or ACLFInstitute for Clinical and Experimental Medicine
- RECRUITINGPHASE1, PHASE2NCT05989958The Safety ,Tolerability and Efficacy Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver FailureHexaell Biotech Co., Ltd.